Szu-Ying Chen

University of California, San Francisco

H-index: 4

North America-United States

About Szu-Ying Chen

Szu-Ying Chen, With an exceptional h-index of 4 and a recent h-index of 4 (since 2020), a distinguished researcher at University of California, San Francisco, specializes in the field of cancer immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Attenuation of the severity and changes in the microbiota in an animal model of primary biliary cholangitis by FOXP3− regulatory T cells

TGFβ: Signaling blockade for cancer immunotherapy

Tgfbm3b is a natural germline genetic variant that modifies anti-tumor responses to anti-PD-1 immunotherapy through its action on the tumor microenvironment

Integrin αvβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy

Szu-Ying Chen Information

University	University of California, San Francisco
Position	___
Citations(all)	97
Citations(since 2020)	82
Cited By	31
hIndex(all)	4
hIndex(since 2020)	4
i10Index(all)	3
i10Index(since 2020)	3
Email	Access Email
University Profile Page	University of California, San Francisco
Google Scholar	View Google Scholar Profile

Szu-Ying Chen Skills & Research Interests

cancer immunology

Szu-Ying Chen

University of California, San Francisco

About Szu-Ying Chen

Szu-Ying Chen Information

Szu-Ying Chen Skills & Research Interests

Top articles of Szu-Ying Chen

Attenuation of the severity and changes in the microbiota in an animal model of primary biliary cholangitis by FOXP3− regulatory T cells

TGFβ: Signaling blockade for cancer immunotherapy

Tgfbm3b is a natural germline genetic variant that modifies anti-tumor responses to anti-PD-1 immunotherapy through its action on the tumor microenvironment

Szu-Ying Chen

Integrin αvβ8 on T cells suppresses anti-tumor immunity in multiple models and is a promising target for tumor immunotherapy

Szu-Ying Chen

Xin Ren

Bing Yang

Tatsuya Tsukui